IGC Pharma Inc (IGC)
0.458
+0.03
(+6.51%)
USD |
NYAM |
Apr 26, 16:00
0.48
+0.02
(+4.80%)
After-Hours: 20:00
IGC Pharma Net Income (Quarterly): -5.589M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.589M |
| September 30, 2023 | -2.451M |
| June 30, 2023 | -2.075M |
| March 31, 2023 | -4.03M |
| December 31, 2022 | -2.249M |
| September 30, 2022 | -2.442M |
| June 30, 2022 | -2.785M |
| March 31, 2022 | -6.503M |
| December 31, 2021 | -2.381M |
| September 30, 2021 | -4.344M |
| June 30, 2021 | -1.788M |
| March 31, 2021 | -2.949M |
| December 31, 2020 | -2.323M |
| September 30, 2020 | -1.657M |
| June 30, 2020 | -1.882M |
| March 31, 2020 | -3.154M |
| December 31, 2019 | -1.603M |
| September 30, 2019 | -1.179M |
| June 30, 2019 | -1.379M |
| March 31, 2019 | -1.578M |
| December 31, 2018 | -1.148M |
| September 30, 2018 | -0.859M |
| June 30, 2018 | -0.512M |
| March 31, 2018 | -0.575M |
| December 31, 2017 | -0.533M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.304M |
| June 30, 2017 | -0.4321M |
| March 31, 2017 | -0.7577M |
| December 31, 2016 | -0.1116M |
| September 30, 2016 | -0.5839M |
| June 30, 2016 | -0.3836M |
| March 31, 2016 | -1.423M |
| December 31, 2015 | -0.403M |
| September 30, 2015 | -0.6234M |
| June 30, 2015 | -0.3827M |
| March 31, 2015 | -1.919M |
| December 31, 2014 | -0.5901M |
| September 30, 2014 | -0.8874M |
| June 30, 2014 | -1.201M |
| March 31, 2014 | -1.463M |
| December 31, 2013 | -0.3105M |
| September 30, 2013 | -0.6152M |
| June 30, 2013 | -0.6335M |
| March 31, 2013 | -1.892M |
| December 31, 2012 | 0.3109M |
| September 30, 2012 | -0.1427M |
| June 30, 2012 | -0.5283M |
| March 31, 2012 | -4.192M |
| December 31, 2011 | -1.901M |
| September 30, 2011 | -0.7893M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-6.503M
Minimum
Mar 2022
-1.179M
Maximum
Sep 2019
-2.777M
Average
-2.381M
Median
Dec 2021
Net Income (Quarterly) Benchmarks
| CEL-SCI Corp | -6.710M |
| AIM ImmunoTech Inc | -12.58M |
| NovaBay Pharmaceuticals Inc | -4.108M |
| Protalix BioTherapeutics Inc | -6.044M |
| Palatin Technologies Inc | -7.844M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.204M |
| Total Expenses (Quarterly) | 3.202M |
| EPS Diluted (Quarterly) | -0.09 |
| Enterprise Value | 26.17M |
| Gross Profit Margin (Quarterly) | 65.20% |
| Profit Margin (Quarterly) | -2.74K% |
| Earnings Yield | -58.17% |
| Normalized Earnings Yield | -48.96 |